{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:56:49Z","timestamp":1780606609677,"version":"3.54.1"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Anti-IgLON5 antibody-related encephalitis is a rare autoimmune disorder of the central nervous system, predominantly occurring in middle-aged elderly individuals, with paediatric cases being exceptionally rare. This study aims to enhance the understanding of paediatric anti-IgLON5 antibody-related encephalitis by summarising its clinical and therapeutic characteristics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>A retrospective analysis was conducted on two paediatric patients diagnosed with anti-IgLON5 antibody-related encephalitis at Hunan Children\u2019s Hospital from August 2022 to November 2023. This involved reviewing their medical records and follow-up data, in addition to a literature review.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The study involved two patients, one male and one female, aged between 2.5 and 9.6\u2009years, both presenting with an acute\/subacute course of illness. Clinically, both exhibited movement disorders (including dystonia, involuntary movements, and ataxia), cognitive impairments, sleep disturbances, and psychiatric symptoms. Patient 1 experienced epileptic seizures, while Patient 2 exhibited brainstem symptoms and abnormal eye movements. Neither patient showed autonomic dysfunction. Patient 1 had normal cerebrospinal fluid (CSF) and Brain MRI findings, whereas Patient 2 showed moderate leukocytosis and mild protein elevation in the CSF, and Brain MRI revealed symmetrical lesions in the basal ganglia and cerebellum. Oligoclonal bands in the CSF were positive in both cases. Both patients tested negative for HLA-DQB*05:01 and HLA-DRB*10:01. They received both first-line and second-line immunotherapies, with Patient 2 showing a poor response to treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Paediatric cases of anti-IgLON5 antibody-related encephalitis similarly present sleep disturbances as a core symptom, alongside various forms of movement disorders. Immunotherapy is partially effective. Compared to adult patients, these paediatric cases tend to exhibit more pronounced psychiatric symptoms, a more rapid onset, and more evident inflammatory changes in the CSF. The condition appears to have a limited association with HLA-DQB*05:01 and HLA-DRB*10:01 polymorphisms.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2024.1388970","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T04:32:19Z","timestamp":1714710739000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical analysis and literature review of two paediatric cases of anti-IgLON5 antibody-related encephalitis"],"prefix":"10.3389","volume":"15","author":[{"given":"Mei","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,3]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","article-title":"A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study","volume":"13","author":"Sabater","year":"2014","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12974-016-0689-1","article-title":"Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome","volume":"13","author":"Sabater","year":"2016","journal-title":"J Neuroinflammation"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e663","DOI":"10.1212\/NXI.0000000000000663","article-title":"Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient","volume":"7","author":"Cellucci","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fnins.2017.00038","article-title":"Promoter-specific expression and genomic structure of IgLON family genes in mouse[J]","volume":"11","author":"Vanaveski","year":"2017","journal-title":"Front Neurosci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nature02399","article-title":"The DNA sequence and biology of human chromosome 19","volume":"428","author":"Grimwood","year":"2004","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/ana.25857","article-title":"Effects of IgLON5 antibodies on neuronal cytoskeleton: a link between autoimmunity and neurodegeneration","volume":"88","author":"Landa","year":"2020","journal-title":"Ann Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.3390\/genes14101886","article-title":"The role of IgLON cell adhesion molecules in neurodegenerative diseases","volume":"14","author":"Salluzzo","year":"2023","journal-title":"Genes"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12974-022-02520-z","article-title":"Anti-IgLON5 antibodies cause progressive behavioral and neuropathological changes in mice","volume":"19","author":"Ni","year":"2022","journal-title":"J Neuroinflammation"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"599384","DOI":"10.3389\/fneur.2020.599384","article-title":"Tauopathy and movement disorders-unveiling the chameleons and mimics","volume":"11","author":"Ganguly","year":"2020","journal-title":"Front Neurol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/brain\/awaa097","article-title":"Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes","volume":"143","author":"Murley","year":"2020","journal-title":"Brain"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00401-016-1591-8","article-title":"Neuropathological criteria of anti-IgLON5-related tauopathy","volume":"132","author":"Gelpi","year":"2016","journal-title":"Acta Neuropathol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1093\/brain\/awac090","article-title":"Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease","volume":"146","author":"Gr\u00fcter","year":"2023","journal-title":"Brain"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e1367","DOI":"10.1212\/WNL.0000000000012639","article-title":"Frequency and characterization of movement disorders in anti-IgLON5 disease","volume":"97","author":"Gaig","year":"2021","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.cca.2021.07.008","article-title":"Anti-IgLON5 disease in a pediatric patient with Langerhans cell histiocytosis","volume":"521","author":"Ye","year":"2021","journal-title":"Clinica Chim Acta"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1195341","DOI":"10.3389\/fimmu.2023.1195341","article-title":"Case report: anti-IgLON5 disease and anti-LGI1 encephalitis following COVID-19","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1159\/000522234","article-title":"Anti-IgLON5 encephalopathy with concomitant herpes virus encephalitis","volume":"29","author":"Wang","year":"2022","journal-title":"Neuroimmunomodulation"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e200126","DOI":"10.1212\/NXI.0000000000200126","article-title":"Anti-LGI1 encephalitis with co-occurring IgLON5 antibodies: clinical features and human leukocyte antigen haplotypes","volume":"10","author":"Schiff","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e15706","DOI":"10.1097\/MD.0000000000015706","article-title":"Autoimmune encephalitis with anti-IgLON5 and anti-GABAB-receptor antibodies: a case report","volume":"98","author":"Chung","year":"2019","journal-title":"Medicine"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","article-title":"Clinical manifestations of the anti-IgLON5 disease","volume":"88","author":"Gaig","year":"2017","journal-title":"Neurology"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"577999","DOI":"10.1016\/j.jneuroim.2022.577999","article-title":"Epileptic seizures in patients with anti-IgLON5 disease","volume":"373","author":"Wang","year":"2022","journal-title":"J Neuroimmunol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1001\/jamaneurol.2019.3638","article-title":"Distinctive magnetic resonance imaging findings in IgLON5 antibody disease","volume":"77","author":"Chen","year":"2020","journal-title":"JAMA Neurol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"zsz133","DOI":"10.1093\/sleep\/zsz133","article-title":"Characterization of the sleep disorder of anti-IgLON5 disease","volume":"42","author":"Iranzo","year":"2019","journal-title":"Sleep"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1212\/NXI.0000000000000136","article-title":"Sleep disorder, chorea, and dementia associated with IgLON5 antibodies","volume":"2","author":"Sabater","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"6(6)","DOI":"10.1212\/NXI.0000000000000605","article-title":"HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease","volume":"6","author":"Gaig","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"16100","DOI":"10.1038\/nrdp.2016.100","article-title":"Narcolepsy","volume":"3","author":"Kornum","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.5664\/jcsm.10748","article-title":"A series of 7 cases of patients with narcolepsy with hypocretin deficiency without the HLA DQB1*06:02 allele","volume":"19","author":"Miano","year":"2023","journal-title":"J Clin Sleep Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"msad231","DOI":"10.1093\/molbev\/msad231","article-title":"Natural selection signatures in the Hondo and Ryukyu Japanese subpopulations","volume":"40","author":"Liu","year":"2023","journal-title":"Mol Biol Evol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e001164","DOI":"10.1136\/jitc-2020-001164","article-title":"Risk of immunotherapy-related narcolepsy in genetically predisposed patients: a case report of narcolepsy after administration of pembrolizumab","volume":"8","author":"Natori","year":"2020","journal-title":"J Immunother Cancer"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1111\/ene.14771","article-title":"Whole\u2010exome sequencing reveals the major genetic factors contributing to neuromyelitis optica spectrum disorder in Chinese patients with aquaporin 4\u2010IgG seropositivity","volume":"28","author":"Zhong","year":"2021","journal-title":"Eur J Neurol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"5057","DOI":"10.1007\/s10072-022-06102-y","article-title":"HLA-DQB1*05:02, *05:03, and *03:01 alleles as risk factors for myasthenia gravis in a Spanish cohort","volume":"43","author":"Salvado","year":"2022","journal-title":"Neurol Sci"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ene.12525","article-title":"High frequency of DQB1*05 and absolute absence of DRB1*13 in muscle-specific tyrosine kinase positive myasthenia gravis","volume":"22","author":"Nikolic","year":"2015","journal-title":"Eur J Neurol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11940-018-0515-4","article-title":"Anti-IgLON 5 disease","volume":"20","author":"Heidbreder","year":"2018","journal-title":"Curr Treat Options Neurol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/ene.15117","article-title":"Expanding the clinical Spectrum of anti-IgLON5 disease: a multicenter retrospective study","volume":"29","author":"Ni","year":"2021","journal-title":"Eur J Neurol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s00415-019-09221-3","article-title":"Intravenous immunoglobulins as first-line therapy for IgLON5 encephalopathy","volume":"266","author":"Logmin","year":"2019","journal-title":"J Neurol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e1116","DOI":"10.1212\/NXI.0000000000001116","article-title":"IgG4-mediated neurologic autoimmunities: understanding the pathogenicity of IgG4, ineffectiveness of IVIg, and long-lasting benefits of anti-B cell therapies","volume":"9","author":"Dalakas","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"852215","DOI":"10.3389\/fimmu.2022.852215","article-title":"Anti-IgLON5 disease \u2013 the current state of knowledge and further perspectives","volume":"13","author":"Madetko","year":"2022","journal-title":"Front Immunol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1056\/NEJMcpc2115844","article-title":"Case 1-2022: a 67-year-old Man with motor neuron disease and odd behaviors during sleep","volume":"386","author":"Videnovic","year":"2022","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1388970\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T04:32:22Z","timestamp":1714710742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1388970\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,3]]},"references-count":37,"alternative-id":["10.3389\/fneur.2024.1388970"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1388970","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,3]]},"article-number":"1388970"}}